Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Change in Cash (2020 - 2025)

Historic Change in Cash for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $15.0 million.

  • LifeStance Health's Change in Cash fell 429.5% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.3 million, marking a year-over-year increase of 6878.52%. This contributed to the annual value of $75.7 million for FY2024, which is 35421.02% up from last year.
  • According to the latest figures from Q3 2025, LifeStance Health's Change in Cash is $15.0 million, which was down 429.5% from $54.6 million recorded in Q2 2025.
  • In the past 5 years, LifeStance Health's Change in Cash registered a high of $54.6 million during Q2 2025, and its lowest value of -$64.1 million during Q4 2021.
  • Moreover, its 5-year median value for Change in Cash was $11.3 million (2023), whereas its average is $732058.8.
  • As far as peak fluctuations go, LifeStance Health's Change in Cash tumbled by 48267.72% in 2023, and later skyrocketed by 23169.48% in 2024.
  • Over the past 5 years, LifeStance Health's Change in Cash (Quarter) stood at -$64.1 million in 2021, then surged by 128.53% to $18.3 million in 2022, then surged by 98.08% to $36.2 million in 2023, then surged by 43.45% to $52.0 million in 2024, then crashed by 71.18% to $15.0 million in 2025.
  • Its Change in Cash was $15.0 million in Q3 2025, compared to $54.6 million in Q2 2025 and -$20.2 million in Q1 2025.